4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000105
Chief Legal Officer sold 2,920 shares at $20.67 ($60,350)
- Chief Legal Officer acquired 7,674 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · Chief Legal Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-30 | Exercise or conversion : show line 1 in the form | +1,924 | 21,762 | D | ||
| 2024-07-30 | Exercise or conversion : show line 2 in the form | +2,000 | 23,762 | D | ||
| 2024-07-30 | Exercise or conversion : show line 3 in the form | +3,750 | 27,512 | D | ||
| 2024-07-30 | Sale : show line 4 in the form | −2,920 | $20.67 | $60,350 | 24,592 | D |
| Open-market sales · 2,920 sh · avg $20.67 · $60,350 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-07-30 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −1,924 | 11,545 | D |
| 2024-07-30 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −2,000 | 14,000 | D |
| 2024-07-30 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −3,750 | 41,250 | D |
Loading xslF345X05/wk-form4_1722380764.xml…